Dynamic networks reveal key players in aging

TL;DR

This paper introduces a method to analyze dynamic, age-specific biological networks to identify genes associated with aging, revealing local topological changes that correlate with aging processes.

Contribution

The study integrates static biological networks with gene expression data to construct dynamic networks, enabling the detection of age-related local topological changes in genes.

Findings

Local gene topologies change with age, while global network structure remains stable.

Predicted aging-related genes significantly overlap with known aging genes.

Predictions are functionally and disease-enriched, linking to human aging.

Abstract

Motivation: Since susceptibility to diseases increases with age, studying aging gains importance. Analyses of gene expression or sequence data, which have been indispensable for investigating aging, have been limited to studying genes and their protein products in isolation, ignoring their connectivities. However, proteins function by interacting with other proteins, and this is exactly what biological networks (BNs) model. Thus, analyzing the proteins' BN topologies could contribute to understanding of aging. Current methods for analyzing systems-level BNs deal with their static representations, even though cells are dynamic. For this reason, and because different data types can give complementary biological insights, we integrate current static BNs with aging-related gene expression data to construct dynamic, age-specific BNs. Then, we apply sensitive measures of topology to the dynamic BNs to study cellular changes with age. Results: While global BN topologies do not significantly change with age, local topologies of a number of genes do. We predict such genes as aging-related. We demonstrate credibility of our predictions by: 1) observing significant overlap between our predicted aging-related genes and "ground truth" aging-related genes; 2) showing that our aging-related predictions group by functions and diseases that are different than functions and diseases of genes that are not predicted as aging-related; 3) observing significant overlap between functions and diseases that are enriched in our aging-related predictions and those that are enriched in "ground truth" aging-related data; 4) providing evidence that diseases which are enriched in our aging-related predictions are linked to human aging; and 5) validating all of our high-scoring novel predictions via manual literature search.